{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":4,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":64,"n_cols":5,"rows_kept":64,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[11,2,11,3],[12,2,12,3],[15,2,15,3],[21,2,21,3],[21,4,21,5],[22,2,22,3],[22,4,22,5],[23,2,23,3],[23,4,23,5],[24,2,24,3],[25,2,25,3],[26,2,26,3],[27,2,27,3],[30,2,30,3],[30,4,30,5],[31,2,31,3],[31,4,31,5],[32,2,32,3],[32,4,32,5],[33,2,33,3],[34,2,34,3],[38,2,38,3],[39,2,39,3],[40,2,40,3],[43,2,43,3],[44,2,44,3],[48,2,48,3],[51,2,51,3],[51,4,51,5],[52,2,52,3],[52,4,52,5],[53,2,53,3],[53,4,53,5],[54,2,54,3],[56,2,56,3],[57,2,57,3],[58,2,58,3],[59,2,59,3],[60,2,60,3],[63,2,63,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910544850603321"]
[null,null,"Autore",null,"Mallick Umair"]
[null,null,"Titolo",null,"Cardiovascular complications of COVID-19 : risk, pathogenesis and outcomes / / Umair Mallick"]
[null,null,"Pubbl/distr/stampa",null,"Cham, Switzerland : , : Springer, , [2022]"]
[{"$nulls":4},"©2022"]
[null,null,"ISBN",null,"9783030900656"]
[{"$nulls":4},"9783030900649"]
[null,null,"Descrizione fisica",null,"1 online resource (416 pages)"]
[null,null,"Disciplina",null,"614.592414"]
[null,null,"Soggetti",null,"COVID-19 (Disease)"]
[{"$nulls":4},"Cardiovascular system - Diseases"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"Intro -- Contents -- 1 The Epidemiology of CoViD19 and Cardiovascular Diseases -- 1.1 Introduction -- 1.2 Epidemiology -- 1.2.1 Cardiovascular Disease or CoViD19, Which Comes First? -- 1.2.2 The Burden of Cardiovascular Risk Factors in CoViD19 -- 1.2.3 Role of the Pre-existing Cardiovascular Diseases in CoViD19 -- 1.2.4 Critical CoViD19 Complications and Pre-existing Cardiovascular Disease -- 1.2.5 Role of Cardiovascular Complications in CoViD19 Mortality -- 1.3 Discussion -- 1.4 Conclusion -- References -- 2 Virology of CoViD19 -- 2.1 Viral Characteristics -- 2.1.1 Origins of SARS CoV2 -- 2.1.2 Hosts -- 2.1.3 SARS CoV2 Structure -- 2.1.4 SARS CoV2 Affinity and Infectivity -- 2.1.5 SARS CoV2 Variability and Strains -- 2.2 Mechanism of Viral Entry in Cells -- 2.2.1 SARS CoV2 Viral Spike-ACE2 Signaling Mechanisms -- 2.2.2 SARS COV, Cell Entry, and Receptors -- 2.2.3 SARS CoV2 Similarities with SARS COV and MERS -- 2.2.4 SARS CoV2, Cell Entry and Receptors -- 2.3 Summary -- References -- 3 An Introduction to the Clinical and Diagnostic Features, and CoViD19 Complications -- 3.1 Introduction -- 3.2 Clinical Symptomatology -- 3.3 Sepsis and Complications of CoViD19 -- 3.4 Important Diagnostic Features -- 3.4.1 Viral Sampling -- 3.4.2 Biochemical and Hematological Features -- 3.4.3 Radiological Features -- 3.5 Summary -- References -- 4 The Pathological Features of CoViD19 Cardiovascular Complications -- 4.1 Introduction -- 4.2 Key Features of Cardiovascular Pathology -- 4.2.1 The Myocardial Injury in CoViD19 "]
[{"$nulls":4},"-- 4.2.2 Endomyocardial Biopsy and Myocarditis -- 4.2.3 Endomyocardial Biopsy and Myocarditis with Viral Localization -- 4.2.4 The Vascular Injury, Microvascular Cardiac Involvement, and Thromboembolic Features -- 4.2.5 Endothelial Cell Infection and Apoptosis -- 4.3 Summary -- References -- 5 Treatment Options in CoViD19 -- 5.1 Introduction."]
[{"$nulls":4},"5.2 Antiviral Agents in CoViD19 -- 5.2.1 Viral Cell Entry Inhibition and Viral Assembly Blockage -- 5.3 Amino Quinolones in CoViD19 -- 5.3.1 Analysis of Body of Evidence on Amino Quinolones in CoViD19 -- 5.4 Immune-Based Therapies in CoViD19 -- 5.4.1 Immunomodulatory Agents -- 5.4.2 Convalescent Plasma, and Antibody-Based Therapies -- 5.5 Potential Anti-inflammatory Mechanisms -- 5.5.1 NOD-Like Receptor Protein 3 (NLRP3)-Anti-inflammasomes -- 5.5.2 Neutrophil Extracellular Traps (NETs)-Anti NETosis Therapy -- 5.6 Anticoagulants -- 5.7 CoViD19 Vaccines -- 5.8 Summary -- References -- 6 An Introduction to the Pathogenetic Mechanisms of CoViD19 Complications -- 6.1 Introduction -- 6.2 Acute Pulmonary Injury -- 6.3 Sepsis and Multi-organ Failure -- 6.4 Renin Angiotensin System -- 6.5 Endothelin System -- 6.6 Immune-Inflammation -- 6.7 Summary -- References -- 7 Overview of Cytokines and CoViD19 -- 7.1 Introduction -- 7.2 Cytokines -- 7.2.1 Interferon -- 7.2.2 Interleukins -- 7.2.3 Chemokines -- 7.2.4 Colony Stimulating Factors -- 7.2.5 Tumor Necrosis Factor -- 7.3 Cytokine Storm in CoViD19 -- 7.3.1 Kinetics of the Cytokine Storm -- 7.3.2 The \"T\" Cell Response -- 7.3.3 Cytokines and Severity of CoViD19 -- 7.4 Cytokines in Cardiovascular and Metabolic Diseases -- 7.5 Summary -- References -- 8 The Renin-Angiotensin System in COVID19 -- 8.1 Introduction -- 8.2 The Renin Angiotensin System -- 8.2.1 ACE2 Synthesis and Distribution -- 8.2.2 ACE2 Expression -- 8.2.3 ACE2 Detection -- 8.3 The Dynamics of ACE2 Expression in CoViD19 -- 8.3.1 ACE2 Expression in Cardiovascular and Metabolic Conditions -- 8.3.2 The Dynamics of ACE2 Expression and Cardiovascular Risk in CoViD19 -- 8.3.3 Age and Gender Variations of ACE2 and CoViD19 -- 8.4 ACE2 is a Marker of Severity or a Compensatory Mechanism? -- 8.5 Summary -- References -- 9 Thrombosis in CoViD19."]
[{"$nulls":4},"9.1 Epidemiology -- 9.2 Mechanisms Promoting Thrombosis in CoViD19 -- 9.2.1 Renin Angiotensin System and Thrombosis -- 9.2.2 Endothelial Cell Damage and Thrombosis -- 9.2.3 Inflammation and Thrombosis -- 9.2.4 Microangiopathy and Thrombosis in CoViD19 -- 9.2.5 Platelets and Thrombosis in CoViD19 -- 9.2.6 D Dimers in CoViD19 -- 9.2.7 Hypoxia and Thrombosis -- 9.2.8 Ethnic Disparities, High-Risk Subgroups and Coagulation -- 9.3 Summary -- References -- 10 Pathogenesis of CoViD19-Miscellaneous Mechanisms -- 10.1 Introduction -- 10.2 Regulatory Peptide Systems in CoViD19 -- 10.2.1 Kallikrein-Kinin System -- 10.2.2 Endothelin System -- 10.2.3 Natriuretic Peptide System -- 10.3 Miscellaneous Mechanisms -- 10.3.1 Direct Viral Damage -- 10.3.2 Endoplasmic Reticulum Stress -- 10.3.3 Cell Death Modalities -- 10.3.4 Mitochondrial Dysfunction -- 10.4 Summary -- References -- 11 Myocardial Injury in CoViD19 -- 11.1 Introduction -- 11.2 Epidemiology of Myocardial Injury -- 11.3 Definition, Presentation, and Challenges of Myocardial Injury -- 11.4 Timing and Assessment of Myocardial Injury -- 11.5 Biomarkers of Myocardial Injury -- 11.6 Pathogenesis of the Myocardial Injury -- 11.7 Summary -- References -- 12 Heart Failure in CoViD19 -- 12.1 Epidemiology -- 12.2 Role of Comorbidities in Heart Failure with CoViD19 -- 12.3 Biomarkers of Heart Failure in CoViD19 -- 12.4 Pathogenetic Mechanisms of Heart Failure in CoViD19 -- 12.5 Summary -- References -- 13 Hypertension in CoViD19 -- 13.1 Epidemiology -- "]
[{"$nulls":4},"13.2 Complexities in Hypertension and CoViD19 -- 13.3 CoViD19 Susceptibility and Hypertension -- 13.4 Pathogenesis -- 13.5 Summary -- References -- 14 Cardiac Arrhythmias in CoViD19 -- 14.1 Epidemiology of Arrhythmias in CoViD19 -- 14.2 Pathogenesis of Arrhythmias in CoViD19 -- 14.3 Summary -- References -- 15 Acute Coronary Syndromes in CoViD19."]
[{"$nulls":4},"15.1 Epidemiology of Acute Coronary Syndromes in CoViD19 -- 15.2 Defining Acute Coronary Syndromes, Challenges in Presentation and Assessment -- 15.3 Pathogenesis of Acute Coronary Syndromes in CoViD19 -- 15.4 Summary -- References -- 16 Diabetes Mellitus and COVID19 -- 16.1 Epidemiology -- 16.2 Pathogenesis -- 16.3 Treatment Implications -- 16.4 Summary -- References -- 17 Obesity and COVID19 -- 17.1 Introduction -- 17.2 Pathogenetic Links - Obesity and CoViD19 -- 17.3 Summary -- References -- 18 The Older Age Adults and COVID19 -- 18.1 Epidemiology -- 18.1.1 Oder Age and CoViD19 Criticality -- 18.1.2 CoViD19 Fatality in Older Age Adults -- 18.1.3 Older Age and Cardiovascular Disease in CoViD19 -- 18.2 CoViD19 Biomarkers in Older Adults -- 18.3 Risk Mechanisms in Older Age and CoViD19 -- 18.3.1 Immune Dysfunction and Inflammation -- 18.3.2 ACE2 Mechanisms -- 18.3.3 Miscellaneous Age Related Mechanisms -- 18.4 Summary -- References -- 19 Gender Disparity in CoViD19 -- 19.1 Epidemiology -- 19.2 Discrepancies in the Epidemiological Data -- 19.3 Factors Associated with Gender Dichotomy -- 19.4 Gender Disparity in Immune Response -- 19.5 Gender Disparity in ACE2 Mechanisms -- 19.6 Gender Disparity in Cardiovascular Diseases -- 19.6.1 Cardiovascular Pathogenetic Features and Gender -- 19.7 Summary -- References -- 20 An Overview of Quality of Research in COVID19 -- 20.1 Introduction -- 20.2 Quality Issues in CoViD19 Research and Improvement Initiatives -- 20.3 Summary -- References -- Index."]
[null,"2.","Record Nr.",null,"UNISOBSOBE00074629"]
[null,null,"Autore",null,"Spinola, Fabio Ambrogio <1593-1671>"]
[null,null,"Titolo",null,"1: Parte prima. Cominciando dalla prima domenica dell'Auuento fino a quella della santissima Trinitá"]
[null,null,"Pubbl/distr/stampa",null,"In Genoua, : per Benedetto Guasco, 1652"]
[null,null,"Descrizione fisica",null,"[16], 528, [8] p. ; 8°"]
[null,null,"Lingua di pubblicazione",null,"Italiano"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Stemma dei gesuiti sul frontespizio. - Segnatura: [croce] A-2K⁸ 2L⁴"]
[null,"3.","Record Nr.",null,"UNISA996207191603316"]
[null,null,"Autore",null,"Mikalson Jon D. <1943->"]
[null,null,"Titolo",null,"Greek popular religion in Greek philosophy [[electronic resource] /] / Jon D. Mikalson"]
[null,null,"Pubbl/distr/stampa",null,"Oxford, : Oxford University Press, 2010"]
[null,null,"ISBN",null,"0-19-161467-X"]
[{"$nulls":4},"9786612639609"]
[{"$nulls":4},"0-19-157678-6"]
[{"$nulls":4},"1-282-63960-9"]
[null,null,"Descrizione fisica",null,"1 online resource (315 p.)"]
[null,null,"Disciplina",null,"180"]
[null,null,"Soggetti",null,"Philosophy, Ancient"]
[{"$nulls":4},"Philosophy and religion - Greece - History"]
[{"$nulls":4},"Greece Religion"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and indexes."]
[null,null,"Nota di contenuto",null,"\"\"Contents\"\"; \"\"Abbreviations\"\"; \"\"Introduction\"\"; \"\"1. â€?Service to the Godsâ€?\"\"; \"\"2. Prayer, Sacrifice, Festivals, Dedications, and Priests in â€?Service to the Godsâ€?\"\"; \"\"3. Divination and Its Range of Influence\"\"; \"\"4. â€?Proper Respect for the Godsâ€? and â€?Religious Correctnessâ€?\"\"; \"\"5. â€?Religious Correctnessâ€? and Justice\"\"; \"\"6. Philosophers and the Benevolence of the Greek Gods\"\"; \"\"Appendix: Polling the Greeks and Their Philosophers\"\"; \"\"References\"\"; \"\"Index of passages cited\"\"; \"\"General index\"\"; \"\"A\"\"; \"\"B\"\"; \"\"C\"\"; \"\"D\"\"; \"\"E\"\"; \"\"F\"\"; \"\"G\"\"; \"\"H\"\"; \"\"I\"\"; \"\"J\"\""]
[{"$nulls":4},"\"\"K\"\"\"\"L\"\"; \"\"M\"\"; \"\"N\"\"; \"\"O\"\"; \"\"P\"\"; \"\"R\"\"; \"\"S\"\"; \"\"T\"\"; \"\"U\"\"; \"\"V\"\"; \"\"W\"\"; \"\"X\"\"; \"\"Z\"\""]
[null,null,null,"Sommario/riassunto","This is a study of how Socrates, Plato, Aristotle, and other Greek philosophers described, interpreted, criticized, and utilized the components and concepts of the religion of the people of their time. These include the practices of sacrifice prayer, dedications, and divination, and the governing concepts of piety and impiety."]
[null,"4.","Record Nr.",null,"UNINA9910809063203321"]
[null,null,"Autore",null,"Neil Linda"]
[null,null,"Titolo",null,"All is given : a memoir in songs / / Linda Neil"]
[null,null,"Pubbl/distr/stampa",null,"Queensland, Australia : , : University of Queensland Press, , 2016"]
[{"$nulls":4},"©2016"]
[null,null,"Descrizione fisica",null,"1 online resource (246 p.)"]
[null,null,"Disciplina",null,"808.06691"]
[null,null,"Soggetti",null,"Travel writing"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,"Nota di contenuto",null,"Cover; Author biography; Praise for Learning How to Breathe; Title page; Imprint page; Dedication; Contents; Prologue: Songbook; Spike and Me: A Fantastic Adventure; Bahut Acha in Bharatpur; The Flower Lady of Zhongshan Park; Singing Love Songs in Kathmandu; My Summer of Peripheries; Revolution at the Peace Hotel; Wild Strawberries in Mongolia; Garbo Laughs in Paris; On Kindness in Kolkata; Notes from the Musical Frontier; Epilogue: All Is Given; Acknowledgements"]